中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2014年
3期
526-528
,共3页
高渗氯化钠羟乙基淀粉40%胃癌根治术%血流动力学%电解质
高滲氯化鈉羥乙基澱粉40%胃癌根治術%血流動力學%電解質
고삼록화납간을기정분40%위암근치술%혈류동역학%전해질
Hemodilution with hypertonic sodium chloride hydroxyethyl starch 40%Hemodilution%Radical correction of gastric cancer%Hemodynamics%Electrolyte
目的 观察应用高渗氯化钠羟乙基淀粉40注射液(HH40)行血液稀释对胃癌根治术患者血流动力学、血电解质及体液平衡的影响.方法 选取全麻下行胃癌根治术患者60例,随机分为高渗氯化钠羟乙基淀粉组(Ⅰ组)和生理盐水组(Ⅱ组),各30例.在手术进腹后达到麻醉深度稳定[脑双频指数(BIS)在55 ~65]时,分别给予HH40和生理盐水4 mL/kg行血液稀释,25 ~ 30 min输完.术中维持BIS为55 ~ 65.应用FloTrac/Vigileo (FV)心排血量监测系统监测心输出量(C0)、每搏输出量(SV)、每搏变异度(SVV)、平均动脉压(MAP)、心率(HR)和中心静脉压(CVP)等血流动力学参数,分别在人室后30 min(麻醉前基础值,T0)、血液稀释前(T1)、血液稀释后即时(T2)、稀释后30 min(T3)、稀释后60 min(T4)及稀释后120 min(T5)记录各项指标.经桡动脉采取血样测定T1、T2、T3、T4及T5时点患者的血钾及血钠浓度.统计总输液量、尿量、出血量及使用麻黄碱例次,观察有无出现过敏或肺水肿征象.结果 Ⅰ组在行血液稀释后(T2)MAP、CO、SV较血液稀释前(T1)明显升高,较对照组也显著升高(P<0.01).Ⅰ组在输注HH40 30 min后(T3)SVV值较Ⅱ组明显降低(P<0.05).Ⅰ组的血钠浓度在血液稀释后较前升高,与Ⅱ组比较亦较高(P<0.05),但尚在正常范围,120 min后(T5)与Ⅱ组比较差异无统计学意义(P>0.05).Ⅰ组的尿量较Ⅱ组明显增加(P<0.05).结论 术中以HH40行血液稀释能有效维持患者的血流动力学稳定,在不增加输液量的情况下增加了肾脏灌注使患者尿量明显增加,对肾功能有保护作用.
目的 觀察應用高滲氯化鈉羥乙基澱粉40註射液(HH40)行血液稀釋對胃癌根治術患者血流動力學、血電解質及體液平衡的影響.方法 選取全痳下行胃癌根治術患者60例,隨機分為高滲氯化鈉羥乙基澱粉組(Ⅰ組)和生理鹽水組(Ⅱ組),各30例.在手術進腹後達到痳醉深度穩定[腦雙頻指數(BIS)在55 ~65]時,分彆給予HH40和生理鹽水4 mL/kg行血液稀釋,25 ~ 30 min輸完.術中維持BIS為55 ~ 65.應用FloTrac/Vigileo (FV)心排血量鑑測繫統鑑測心輸齣量(C0)、每搏輸齣量(SV)、每搏變異度(SVV)、平均動脈壓(MAP)、心率(HR)和中心靜脈壓(CVP)等血流動力學參數,分彆在人室後30 min(痳醉前基礎值,T0)、血液稀釋前(T1)、血液稀釋後即時(T2)、稀釋後30 min(T3)、稀釋後60 min(T4)及稀釋後120 min(T5)記錄各項指標.經橈動脈採取血樣測定T1、T2、T3、T4及T5時點患者的血鉀及血鈉濃度.統計總輸液量、尿量、齣血量及使用痳黃堿例次,觀察有無齣現過敏或肺水腫徵象.結果 Ⅰ組在行血液稀釋後(T2)MAP、CO、SV較血液稀釋前(T1)明顯升高,較對照組也顯著升高(P<0.01).Ⅰ組在輸註HH40 30 min後(T3)SVV值較Ⅱ組明顯降低(P<0.05).Ⅰ組的血鈉濃度在血液稀釋後較前升高,與Ⅱ組比較亦較高(P<0.05),但尚在正常範圍,120 min後(T5)與Ⅱ組比較差異無統計學意義(P>0.05).Ⅰ組的尿量較Ⅱ組明顯增加(P<0.05).結論 術中以HH40行血液稀釋能有效維持患者的血流動力學穩定,在不增加輸液量的情況下增加瞭腎髒灌註使患者尿量明顯增加,對腎功能有保護作用.
목적 관찰응용고삼록화납간을기정분40주사액(HH40)행혈액희석대위암근치술환자혈류동역학、혈전해질급체액평형적영향.방법 선취전마하행위암근치술환자60례,수궤분위고삼록화납간을기정분조(Ⅰ조)화생리염수조(Ⅱ조),각30례.재수술진복후체도마취심도은정[뇌쌍빈지수(BIS)재55 ~65]시,분별급여HH40화생리염수4 mL/kg행혈액희석,25 ~ 30 min수완.술중유지BIS위55 ~ 65.응용FloTrac/Vigileo (FV)심배혈량감측계통감측심수출량(C0)、매박수출량(SV)、매박변이도(SVV)、평균동맥압(MAP)、심솔(HR)화중심정맥압(CVP)등혈류동역학삼수,분별재인실후30 min(마취전기출치,T0)、혈액희석전(T1)、혈액희석후즉시(T2)、희석후30 min(T3)、희석후60 min(T4)급희석후120 min(T5)기록각항지표.경뇨동맥채취혈양측정T1、T2、T3、T4급T5시점환자적혈갑급혈납농도.통계총수액량、뇨량、출혈량급사용마황감례차,관찰유무출현과민혹폐수종정상.결과 Ⅰ조재행혈액희석후(T2)MAP、CO、SV교혈액희석전(T1)명현승고,교대조조야현저승고(P<0.01).Ⅰ조재수주HH40 30 min후(T3)SVV치교Ⅱ조명현강저(P<0.05).Ⅰ조적혈납농도재혈액희석후교전승고,여Ⅱ조비교역교고(P<0.05),단상재정상범위,120 min후(T5)여Ⅱ조비교차이무통계학의의(P>0.05).Ⅰ조적뇨량교Ⅱ조명현증가(P<0.05).결론 술중이HH40행혈액희석능유효유지환자적혈류동역학은정,재불증가수액량적정황하증가료신장관주사환자뇨량명현증가,대신공능유보호작용.
Objective To observe the effect of hemodilution with hypertonic sodium chloride hydroxyethyl starch 40 injection (HH40) on the electrolytes,hemodynamics and fluid balance of patients treated by radical correction of gastric cancer.Methods Approved by hospital ethics committee.A total of 60 patients who treated by radical correction of gastric cancer under general anesthesia at our hospital were randomly divided equally into 2 groups:group Ⅰ (hemodilution) and group Ⅱ (control) (n =30each).After the abdominal cavity was opened and the depth of anesthesia is stable (Bispectral index (BIS) value is maintained at 55-65),hypertonic sodium chloride hydroxyethyl starch 40 injection was infused at the total of 4 ml/kg in group Ⅰ,while patients in group Ⅱ received saline at the total of 4 m]/kg,finished between 25 and 30 minutes.Regulating the depth of anesthesia according to BIS values (55-65)intraoperative.Cardiac output (CO),stroke volume (SV),every stroke variability (SVV),mean arterial pressure (MAP),heart rate (HR) and central venous pressure (CVP) were recorded at the following time points:T (0) (base) (before induction),T (1) (after induction and hemodynamic stabilization),T (2) (when the infusion is finished),T (3) (after infusion for 30 min),T (4) (after infusion for 60 min) and T (5) (after infusion for 120 min).Blood samples from radial artery were collected and determine the potassium and sodium concentration at the following time points:T (1),T (2),T (3),T (4) and T (5).Add up the total fluid volume,urine output,amount of bleeding.The dosing frequency of ephedrine was also recorded,to observe the presence or absence of signs of allergy and pulmonary edema.Results MAP,CO and SV at time point T2 in group Ⅰ were significantly higher than that at time point T1,and were significantly higher than that at T2 in group Ⅱ (P < 0.01).SVV in group Ⅰ was significantly lower than that in group Ⅱ (P < 0.05) at the time point T3.[Na +] i in group Ⅰ was significantly higher than that in group Ⅱ after hemodilution (P < 0.05),but no significant difference was found at the time point T5 between groups.The urine output,in group Ⅰ was significantly more than that in group Ⅱ (P <0.01).Conclusion The patient' s hemodynamic stability can be effectively maintained.After the hemodilution with HH40,it will increase renal perfusion without increase the total fluid volume,the urine volume increased significantly.Therefore,the patient' s function of kidney can be effectively protected.